DarioHealth Corp. (Nasdaq: DRIO) (“DarioHealth” or the “Company”), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020 ,
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- DarioHealth (Formerly Known As LabStyle Innovations)Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020, and host a conference call at 9:00am Eastern Time.
![]()
The call will be hosted by Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer. Conference Call Details Date: Wednesday, August 12, 2020 Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through August 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 36466. The webcast replay will be available through November 12, 2020. About DarioHealth Corp. DarioHealth Contact: Investor Relations Contact:
SOURCE DarioHealth Corp. |
||
Company Codes: Berlin:LS1P, NASDAQ-SMALL:DRIO, Munich:LS1P, Stuttgart:LS1P |